Current status:
Cancelled Post Market
Current status date:
2021-03-01
DIN:
02216728
Electronic product monograph is not available
Company:
AKORN INC
300
1925 West Field Ct
Lake Forest
Illinois
United States
60045
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
American Hospital Formulary Service (AHFS):
See footnote 3
52:16.00
,
36:58.00
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01JA51 FLUORESCEIN, COMBINATIONS
List of active ingredient(s)
Active ingredient(s) |
Strength |
BENOXINATE HYDROCHLORIDE
|
0.4 %
|
FLUORESCEIN SODIUM
|
0.25 %
|